Skip to content
Sjogren's Syndrome News logo
  • Sjogren's Syndrome News on Facebook
  • Sjogren's Syndrome News on X
  • About Sjögren's
    What is Sjögren’s syndrome?
    Symptoms
    Causes
    Diagnosis
  • News
  • Columns
    Archived Columns
    • Diary of a Sjogie — Rena Newman
  • Health insights
  • FAQs
  • Clinical trials
    What are clinical trials?
    Types of clinical trials
    How do clinical trials work?
    Traditional vs. remote vs. hybrid clinical trials
    FAQs about clinical trials
  • What can we help you find today?

    • Sjogren's Syndrome News on Facebook
    • Sjogren's Syndrome News on X

September 20, 2018 News by Joana Carvalho, PhD

Red Blood Cell Size Linked to Poor Prognosis in Sjogren’s Patients with PAH, Study Shows

Larger differences in the size and volume of red blood cells — measured with a blood parameter called red blood cell distribution width — are linked to poor prognosis and survival in patients with primary Sjogren’s syndrome affected by pulmonary arterial hypertension (PAH), researchers found. Their study, “Red blood…

May 15, 2018 News by José Lopes, PhD

Study Identifies Risk Factors for PAH in Primary Sjogren’s Patients

Raynaud’s phenomenon and liver injury are among the risk factors for the development of pulmonary arterial hypertension (PAH) – high blood pressure in the arteries that goes from the heart to the lungs – in primary Sjogren’s syndrome (pSS) patients, a new study shows. The research, “…

March 8, 2018 News by José Lopes, PhD

Immunosuppressants Can Help Chinese with Sjogren’s Syndrome-linked PAH Live Longer, Study Finds

Chinese who develop pulmonary arterial hypertension (PAH) from primary Sjogren’s syndrome have worse survival rates if their PAH appears late or if they have poorer cardiac function, a new study shows. The findings, published in the journal Lupus, also show that patients taking immunosuppressants have better survival rates. Sjogren’s syndrome,…

Recent Posts

  • Stem cell eye drops show promise for treating dry eye in Sjögren’s
  • Upcoming US clinical trial will test CLN-978 as Sjögren’s treatment
  • Key trial of Sjögren’s treatment expected to launch this summer
  • Men with Sjögren’s may be at higher pulmonary hypertension risk
  • MicroRNA may be therapeutic target for Sjögren’s: Study
  • Salivary gland ultrasound may assess primary Sjögren’s activity
  • Connect, learn, thrive this Sjögren’s Awareness Month, advocates say
  • FDA grants fast track designation to nipocalimab for Sjögren’s disease
  • Sexual dysfunction affects nearly 80% of women with Sjögren’s
  • Younger age, self-reactive antibodies tied to Sjögren’s kidney involvement


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: info@bionews.com
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

  • Sjogren's Syndrome News on Facebook
  • Sjogren's Syndrome News on X
Copyright © 2013-2025 All rights reserved.